Posts

Showing posts with the label Healthcare Costs

Metabolic Health & Employee Benefits — What HR Won't Tell You | 2026

Image
Metabolic Health & Employee Benefits — What HR Won't Tell You | 2026 There's a version of the employee benefits conversation that happens during open enrollment every fall. A benefits coordinator walks through the plan options, explains the deductible tiers, runs through the dental and vision add-ons, and mentions the wellness program in passing — something about a gym reimbursement or a health fair in November. It's a transactional conversation. Efficient. Mostly administrative. And then there's the version of the conversation that doesn't happen in that room — the one happening in the actuarial spreadsheets that determine what those plan options cost in the first place, what the wellness program is actually designed to address, and why certain benefit structures have evolved the way they have over the past decade of employer healthcare cost escalation. That version of the conversation has quite a lot to do with metabolic health. With chronic disease pr...

Healthcare Costs After 50 — Why They Hit Like a Second Mortgage | 2026

Image
Healthcare Costs After 50 — Why They Hit Like a Second Mortgage | 2026 There's a moment — somewhere in the mid-50s for a lot of people — when the abstract concept of "retirement healthcare costs" stops being abstract. Maybe it's the first time a prescription refill comes with a three-digit co-pay. Maybe it's the Medicare enrollment paperwork that arrives in the mail and turns out to be forty pages of decisions nobody prepared you to make. Maybe it's a conversation with a financial planner who says, with practiced calm, that a couple retiring today at 65 may need somewhere north of $300,000 set aside specifically for healthcare expenses over their remaining years — not counting long-term care costs . Three hundred thousand dollars. For healthcare. On top of housing, food, and whatever version of retirement living someone actually planned for. It lands like a second mortgage that nobody listed on the closing documents. The numbers aren't invented...

Employer Wellness & Body Composition Costs — The Shift | 2026

Image
Employer Wellness & Body Composition Costs — The Shift | 2026 The conversation in corporate benefits offices has shifted in a way that would have seemed technical and niche just five years ago. HR leaders and benefits directors at mid- and large-size organizations are now regularly fielding questions about things like lean mass preservation, body composition data beyond BMI, and what happens to muscle tissue during rapid weight loss. Not because they became biology enthusiasts overnight. Because the financial reality of 2026 left them no choice but to look harder at the upstream variables behind their claims data. Employer healthcare costs are projected to average over $17,000 per employee in 2026 — a 9% to 9.5% increase according to multiple actuarial projections, marking the third consecutive year of near-double-digit growth. GLP-1 medications alone are reshaping pharmacy benefit budgets at a rate that benefit managers are describing as unprecedented. And as organization...

Employer Healthcare Budgets & Metabolic Health — The 30-Year Shift | 2026

Image
Employer Healthcare Budgets & Metabolic Health — The 30-Year Shift | 2026 Employer healthcare conversations have always been dominated by the near term. What premiums look like at renewal. What the claims data showed last quarter. Whether this year's deductible structure makes sense given the utilization patterns the actuary is projecting. The planning horizon has been, almost by institutional design, short — one year, maybe three, occasionally five for the more forward‑thinking benefits teams. That horizon is stretching. Slowly, unevenly, driven by pressures that don't fit neatly into an annual renewal cycle — but stretching in ways that are starting to show up in how benefits conversations are actually structured. The forces behind this shift are several and converging. An aging American workforce that is carrying metabolic health conditions into the peak of their working years at historically high prevalence. A generation of GLP‑1 medications whose cost impact ...